BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18289827)

  • 21. [Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome)].
    Gómez A; Salguero G; García H; Aristizábal F; Gutiérrez O; Angel LA; Padrón J; Martínez C; Martínez H; Malaver O; Barvo R; Giraldo A
    Biomedica; 2005 Sep; 25(3):315-24. PubMed ID: 16276679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
    Schiemann U; Papatheodorou L; Glasl S; Gross M
    Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer.
    Renkonen E; Zhang Y; Lohi H; Salovaara R; Abdel-Rahman WM; Nilbert M; Aittomaki K; Jarvinen HJ; Mecklin JP; Lindblom A; Peltomaki P
    J Clin Oncol; 2003 Oct; 21(19):3629-37. PubMed ID: 14512394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
    Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
    Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.
    Mueller-Koch Y; Vogelsang H; Kopp R; Lohse P; Keller G; Aust D; Muders M; Gross M; Daum J; Schiemann U; Grabowski M; Scholz M; Kerker B; Becker I; Henke G; Holinski-Feder E
    Gut; 2005 Dec; 54(12):1733-40. PubMed ID: 15955785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
    Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
    J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer.
    Ward R; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins N; Burgess B; Groombridge C; Spigelman A
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):403-11. PubMed ID: 12200596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and genetic features of International Collaborative Group-hereditary nonpolyposis colorectal cancer families and suspected hereditary nonpolyposis colorectal cancer families.
    Yuan Y; Ye J; Zheng S;
    Chin Med J (Engl); 2004 May; 117(5):748-52. PubMed ID: 15161546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer.
    Overbeek LI; Kets CM; Hebeda KM; Bodmer D; van der Looij E; Willems R; Goossens M; Arts N; Brunner HG; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Br J Cancer; 2007 May; 96(10):1605-12. PubMed ID: 17453009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sixteen rare sequence variants of the hMLH1 and hMSH2 genes found in a cohort of 254 suspected HNPCC (hereditary non-polyposis colorectal cancer) patients: mutations or polymorphisms?
    Müller-Koch Y; Kopp R; Lohse P; Baretton G; Stoetzer A; Aust D; Daum J; Kerker B; Gross M; Dietmeier W; Holinski-Feder E
    Eur J Med Res; 2001 Nov; 6(11):473-82. PubMed ID: 11726306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening the hereditary nonpolyposis colorectal cancer by revised Bethesda guideline: a cohort study of 110 cases].
    Jin HY; Ding YJ; Liu XF; Yang BL; Lai RS; Ni M; Ge YS
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1445-7. PubMed ID: 17785078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes.
    Pensotti V; Radice P; Presciuttini S; Calistri D; Gazzoli I; Grimalt Perez A; Mondini P; Buonsanti G; Sala P; Rossetti C; Ranzani GN; Bertario L; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jul; 19(3):135-42. PubMed ID: 9218993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
    Aaltonen LA; Salovaara R; Kristo P; Canzian F; Hemminki A; Peltomäki P; Chadwick RB; Kääriäinen H; Eskelinen M; Järvinen H; Mecklin JP; de la Chapelle A
    N Engl J Med; 1998 May; 338(21):1481-7. PubMed ID: 9593786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer.
    Kim JC; Kim HC; Roh SA; Koo KH; Lee DH; Yu CS; Lee JH; Kim TW; Lee HL; Beck NE; Bodmer WF
    Cancer Detect Prev; 2001; 25(6):503-10. PubMed ID: 12132870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany.
    Lamberti C; Mangold E; Pagenstecher C; Jungck M; Schwering D; Bollmann M; Vogel J; Kindermann D; Nikorowitsch R; Friedrichs N; Schneider B; Houshdaran F; Schmidt-Wolf IG; Friedl W; Propping P; Sauerbruch T; Büttner R; Mathiak M
    Digestion; 2006; 74(1):58-67. PubMed ID: 17095871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.